Skip to main content
. 2013 Oct 20;2013(10):CD009455. doi: 10.1002/14651858.CD009455.pub2
Summary of results: Pain‐free and headache relief
  Baseline pain Studies Attacks
treated
Treatment
(%)
Placebo or comparator
(%)
Relative benefit (95% CI) NNT
(95% CI)
Pain‐free at 2 h              
Naproxen 500/825 mg vs placebo ≥ mod 4 2149 17 8 2.0 (1.6 to 2.6) 11 (8.7 to 17)
Naproxen 500 mg vs placebo ≥ mod 3 1951 16 9 1.9 (1.5 to 2.4) 13 (9.7 to 22)
Naproxen 500 mg vs sumatriptan 50 mg ≥ mod 1 474 18 20 Not calculated Not calculated
Headache relief at 2 h              
Naproxen 500/825 mg vs placebo ≥ mod 4 2149 45 29 1.6 (1.4 to 1.8) 6.0 (4.8 to 7.9)
Naproxen 500 mg vs placebo ≥ mod 3 1951 44 28 1.6 (1.4 to 1.8) 6.2 (4.9 to 8.3)
Naproxen 500 mg vs sumatriptan 50 mg ≥ mod 1 474 46 49 Not calculated Not calculated
Sustained pain‐free during the 24 h post dose              
Naproxen 500/825 mg vs placebo ≥ mod 4 2149 12 7 1.8 (1.4 to 2.4) 19 (13 to 34)
Naproxen 500 mg vs placebo ≥ mod 3 1951 11 7 1.6 (1.2 to 2.1) 26 (16 to 70)
Naproxen 500 mg vs sumatriptan 50 mg ≥ mod 1 474 12 11 Not calculated Not calculated
Sustained headache relief during the 24 h post dose              
Naproxen 500/825 mg vs placebo ≥ mod 4 2149 30 18 1.7 (1.5 to 2.0) 8.3 (6.4 to 12)
Naproxen 500 mg vs placebo ≥ mod 3 1951 28 17 1.7 (1.4 to 2.0) 9.3 (6.9 to 14)
Naproxen 500 mg vs sumatriptan 50 mg ≥ mod 1 474 25 29 Not calculated Not calculated